Li Jiang, Ghazwani Mohammed, Liu Ke, Huang Yixian, Chang Na, Fan Jie, He Fengtian, Li Liying, Bu Shizhong, Xie Wen, Ma Xiaochao, Li Song
Center for Pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States of America.
Department of Cell Biology,Municipal Laboratory for Liver Protection and Regulation of Regeneration, Capital Medical University, Beijing, China.
PLoS One. 2017 Aug 10;12(8):e0182679. doi: 10.1371/journal.pone.0182679. eCollection 2017.
Liver fibrosis is the excessive accumulation of extracellular matrix proteins, which is mainly caused by accumulation of activated hepatic stellate cells (HSCs). The mechanisms of activation and proliferation of HSCs, two key events after liver damage, have been studied for many years. Here we report a novel pathway to control HSCs by regulating glutamine metabolism. We demonstrated that the proliferation of HSCs is critically dependent on glutamine that is used to generate α-ketoglutarate (α-KG) and non-essential amino acid (NEAA). In addition, both culture- and in vivo-activated HSCs have increased glutamine utilization and increased expression of genes related to glutamine metabolism, including GLS (glutaminase), aspartate transaminase (GOT1) and glutamate dehydrogenase (GLUD1). Inhibition of these enzymes, as well as glutamine depletion, had a significant inhibitory effect on HSCs activation. In addition to providing energy expenditure, conversion of glutamine to proline is enhanced. The pool of free proline may also be increased via downregulation of POX expression. Hedgehog signaling plays an important role in the regulation of glutamine metabolism, as well as TGF-β1, c-Myc, and Ras signalings, via transcriptional upregulation and repression of key metabolic enzymes in this pathway. Finally, changes in glutamine metabolism were also found in mouse liver tissue following CCl4-induced acute injury.
Glutamine metabolism plays an important role in regulating the proliferation and activation of HSCs. Strategies that are targeted at glutamine metabolism may represent a novel therapeutic approach to the treatment of liver fibrosis.
肝纤维化是细胞外基质蛋白的过度积累,主要由活化的肝星状细胞(HSC)积累引起。肝损伤后两个关键事件——HSC的活化和增殖机制已被研究多年。在此,我们报告了一条通过调节谷氨酰胺代谢来控制HSC的新途径。我们证明HSC的增殖严重依赖于用于生成α-酮戊二酸(α-KG)和非必需氨基酸(NEAA)的谷氨酰胺。此外,体外培养和体内活化的HSC均有谷氨酰胺利用率增加以及与谷氨酰胺代谢相关基因(包括谷氨酰胺酶(GLS)、天冬氨酸转氨酶(GOT1)和谷氨酸脱氢酶(GLUD1))表达增加的情况。抑制这些酶以及耗尽谷氨酰胺对HSC活化有显著抑制作用。除了提供能量消耗外,谷氨酰胺向脯氨酸的转化增强。游离脯氨酸池也可能通过下调POX表达而增加。刺猬信号通路在谷氨酰胺代谢的调节中起重要作用,转化生长因子-β1(TGF-β1)、c-Myc和Ras信号通路也是如此,它们通过转录上调和抑制该途径中的关键代谢酶来发挥作用。最后,在四氯化碳诱导的急性损伤后的小鼠肝组织中也发现了谷氨酰胺代谢的变化。
谷氨酰胺代谢在调节HSC的增殖和活化中起重要作用。针对谷氨酰胺代谢的策略可能代表一种治疗肝纤维化的新方法。